Rebecca Auer

Dr. Rebecca Auer is a Professor in the Department of Surgery at the University of Ottawa. She also holds leadership roles as CEO & Scientific Director of the Ottawa Hospital Research Institute and Executive Vice-President Research and Innovation at The Ottawa Hospital. Her research focuses on abdominal malignancies, particularly colorectal cancer and sarcomas, with emphasis on immunotherapy, oncolytic viruses, and surgical stress impacts on metastasis.

Educational Background:

• MD, Queen's University (2000)
• MSc, University of Ottawa (2005)
• Fellowship in Surgical Oncology, Memorial Sloan-Kettering Cancer Center (2007)

Research Interests span the development of oncolytic virus therapies, surgical stress modulation of immune function, coagulation mechanisms in cancer progression, and immunotherapy strategies for colorectal and sarcoma tumors. Her work integrates virology, immunology, and surgical oncology to improve patient outcomes.

Article Trends highlight her expertise in oncolytic virus engineering for colorectal cancer, preclinical models of metastasis, and clinical trials combining virotherapy with immune checkpoint inhibitors. Keywords from her work include Cancer Immunotherapy, Oncolytic Virus Therapy, and Surgical Stress.